Toimprovepatientoutcomesbymakingeverybreathcountandtobecometheindustryleaderby2020
OurVision
Supportedby theEuropeanUnion'sHorizon2020researchandinnovationprogrammeundergrantagreementNo711269
NovelTechnologyatthecoreAbrandnewapproachtoRespiratoryEffortMonitoring-asignificantengineeringchallenge
Measuringthemostsensitiveindicatortowell-beingBreathing:RespiratoryEffortisatotalsystemindicatorofwellnessofferingupto48hoursearlyindicationofsickness
Ongoingresearch&developmentintopreventativemonitoring&diagnostictechnologiesMakingeverybreathcountbydevelopingrealtimebreathbybreathmonitoring- atrueindustryleaderinthisfield
PMDSolutions
Ongoingexcellenceinclinicalandappliedresearch
Constantclinicalinvestigationtoprovetheeffectivenessofourtechnology
Globalfocuswithaninternationalpresence
Genuineconcernoverpatient’soutcomeinacutecaretogetherwithinternationalpartners
• Peopleareliving longer• COPD(respiratorydiseases)3rd biggestkiller by2030• Emergency andUrgentCareunderseverepressure• Disease statessuchassleep disordersgoingundiagnosed forupto2
yearspostsymptomsbeing recognised
• Healthier living:MoreyearsandBetterLife• Betteracutecaremanagement (LowerEventRate)• Reducingpreventable comorbidities thusimprovehealthcare
economics +QualityofLife
Preventativemonitoringiskey,earlydetectionisvital
ImpacttoEuropeanSociety
• OTS tablet device• Android• Disposable single use sensor• Respiratory rate trend
monitoring• Continuous monitoring
4 days battery
In-patient RR monitor
• OTS mobile phone• Android• Zero patient engagement
needed• Cloud processing + report
generation
+
Presentlybothclinical applications usethesamedevice
Respirasense
Home Sleep Test
All comm’s are BT
Platform- 2applications:1product
RS Sleep Screener
RespiraSense
Totriggertheearliestintervention
Andimprovedhealthcareeconomics
Leadingtobetterpatientoutcomes
Thefirstsignofabnormalbreathing
ContinuousrateMonitoringallows;
WhyisRRimportant?
RespiraSense
Costing€18,000perevent
RespiraSensecangive>80%ROIbyimpacting1in20patients
Upto7additionalbeddays
7%GeneralWard&11%Post-op
IncidenceofRespiratoryCompromisetoIncreaseby31%by2020
StatusQuoBandsslip,leadingtore-testsBandsareuncomfortable
PMDischangingtheStatusQuo• Bandsreplacedwithsimple
adhesiveRSsensor• Chest&gutmeasurements
+Position+Activity
Consumerapplicationpotentialforhomescreening
RSSleepScreener
Toincreasetheirpatientcoverage
Toidentifyandservemoreapnoea suffers
Withminimumincreases inresources
Canenablesleepserviceproviders
Asimpleandaccurateeventscreener;
WhyScreen?
Today,avalidatedtechnology
2016Efficacywithallproducts
2017EvaluationofEconomicImpacttoHealthcare
ClinicalEvidence
InternationalTeam- Objectivesa.)EstablishCommercial Pathwayb.)Increase UserBasec.)RetainExisting UserBased.)NetworktheGlobalUserBase
MarketPresence
Application1- buildproposition: InvestmentBusinessPlan,Ifwegotitwhatwouldweactuallywanttodo
Application2– refineExcellence andImpactwithlatestcompanyupdates
Application3– Refineandrefine implementationincluding partners forskill gaps,therightbudget,therightAmbition
1Year
3Attempts
1st inEurope
H2020– OnlyOpportunity forSMEFunding
Bemindful,projectsarereviewedbypeopleSpeakthe language
Tell thestory
Excite themProveit
H2020– AnElementofFundingStrategy
Bigambition&clearplantoexecute
LeveragetoraiseGrowthCapitalfromVCfunds
H2020,oneoptionofmany
Therightvalidatedproposition
PMDfundedbyAngles&H2020
Thankyoufortheopportunity topresentouroffering
MylesMurrayManagingDirector&[email protected]|ModelFarmRoad|Co.Cork|Ireland
SupportedbytheEuropeanUnion'sHorizon2020research andinnovationprogrammeundergrantagreement No711269